Subscribe
Logo small
Search
banner

Enzyme replacement therapy allows LAL-D patients to function normally

MedExpress Team

Piotr Wójcik

Published June 4, 2024 08:00

An interview with Natalia Rospara, president of the LAL-D Patients Association.

A year ago, you founded the LAL-D (acid lysosomal lipase deficiency - editor's note) Patient Association. Please tell us how much this disorder affects patients' lives on a daily basis?

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Similar articles

Zrzut ekranu 2024-06-21 o 10.00.20
Molecular diagnostics

Patients and clinicians await Health Ministry decision

June 28, 2024
ThinkstockPhotos-518878059
June 28, 2024
iStock-1062433666b
June 28, 2024

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.